Seely Lynn Insider Trades

Insider Trading History

Track insider trading activity for Seely Lynn. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
AbCellera Biologics
AbCellera Biologics ABCL
Director
Holding Value $1.03M 152,207 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 152,207 shares
$7.85
$6.74
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $1.05M 73,878 shares
Last Trade
May 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.34k 388 shares
$18.91
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $1.06M 74,266 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$174k 7,455 shares
$23.39
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $1.17M 81,721 shares
Last Trade
Feb 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.1k 438 shares
$23.12
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $2.21M 155,000 shares
Last Trade
Feb 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.68M 155,000 shares
$23.71
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $1.17M 82,159 shares
Last Trade
Feb 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 20,000 shares
$23.25
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $958k 67,159 shares
Last Trade
Nov 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.64k 412 shares
$16.11
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $2.5M 175,000 shares
Last Trade
Oct 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.02M 175,000 shares
$17.23
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $964k 67,571 shares
Last Trade
Aug 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$76.5k 7,257 shares
$10.54
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $1.07M 74,828 shares
Last Trade
Aug 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$426k 40,000 shares
$10.65
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $497k 34,828 shares
Last Trade
Aug 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.2k 406 shares
$10.34
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $502k 35,234 shares
Last Trade
Aug 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.12k 391 shares
$10.53
$14.26
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $1.72M 13,254 shares
Last Trade
Jul 17, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.9M 84,083 shares
$129.46
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $0 0 shares
Last Trade
Jul 17, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$1.72M 13,254 shares
$129.46
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $2.22M 17,156 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 3,902 shares
$128.12
$129.46
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $10.2M 712,500 shares
Last Trade
Mar 14, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.05M 175,000 shares
$11.71
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $19.3M 1,350,000 shares
Last Trade
Feb 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.8M 1,518,750 shares
$11.07
$14.26
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $1.72M 13,254 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$485k 4,570 shares
$106.14
$129.46
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $2.85M 200,000 shares
Last Trade
Feb 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.2M 200,000 shares
$36.00
$14.26
Lyell Immunopharma
Lyell Immunopharma LYEL
President And CEO
Holding Value $0 0 shares
Last Trade
Nov 16, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$281M 7,500,000 shares
$37.40
$14.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up